Inferior Vena Cava Filters: A Clinical Review and Future Perspectives

Author:

Benedetti Raffaella1,Marino Simone2,Tangianu Flavio2,Imberti Davide1

Affiliation:

1. Haemostasis and Thrombosis Center, Department of Internal Medicine, Hospital of Piacenza, 29121 Piacenza, Italy

2. Department of Internal Medicine, Ospedale di Circolo e Fondazione Macchi, 21100 Varese, Italy

Abstract

Anticoagulation represents the first line treatment for venous thromboembolism (VTE). However, inferior vena cava (IVC) filter insertion can be considered as a possible therapeutic strategy when anticoagulant therapy is contraindicated, to avoid embolization from the lower limbs to pulmonary circulation. Other possible indications are debated among experts. Both permanent and retrievable caval filters are available in clinical practice. Retrievable filters can be removed when no longer necessary, as their use may be indicated only for a limited amount of time. Moreover, caval filter insertion is not devoid of possible complications, particularly in cases of permanent or long-dwelling filters. A multidisciplinary approach is recommended to review the appropriateness of caval filter use and to define the best timing for retrieval.

Publisher

MDPI AG

Reference87 articles.

1. 2019 ESC guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS);Konstantinides;Eur. Heart J.,2020

2. Baillère et Fils, J.-B. (1868). Clinique Medicale de l’Hotel de Dieu de Paris, Libraires de l’Académie Impériale de Médecine, Rue Hautefeuille.

3. A new vena cava filter permitting continued flow and resolution of emboli;Greenfiel;Surgery,1973

4. Twenty-one year trend in the use of inferior vena cava filters;Stein;Arch. Intern. Med.,2004

5. U.S. Food and Drug Administration (2024, March 13). Inferior Vena Cava (IVC) Filters: Initial Communication: Risk of Adverse Events with Long-Term Use. Posted online. Published online 9 August 2010, Available online: https://wayback.archive-it.org/7993/20161022180008/http:/www.fda.gov/MedicalDevices/Safety/AlertsandNotices/ucm221676.htm.

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3